- The Infliximab2008 | First Faculty of Medicine
- Biosimilar infliximab in a clinical laboratory practice2016 | First Faculty of Medicine
- MONITORING PATIENTS TREATED WITH INFLIXIMAB: ASSESSING ANTI-INFLIXIMAB ANTIBODIESPublication without faculty affiliation
- Serum infliximab levels, antibodies to infliximab and albumin concentrations during infliximab treatment in patients with inflammatory bowel diseasesPublication without faculty affiliation
- Determination of serum infliximab levels and levels of antibodies against infliximab - when, why and how?Publication without faculty affiliation
- Switch from biosimilar infliximab CT-P13 to biosimilar infliximab SB-2 in the long-term maintenance therapy in IBD patients - prospective observational study2023 | First Faculty of Medicine
- A dissimilar biosimilar? Lichenoid drug eruption induced by an infliximab biosimilar2018 | Faculty of Medicine in Pilsen
- Infliximab dependency in children with Crohn's disease2009 | First Faculty of Medicine
- Subcutaneous infliximab in the treatment of refractory Crohn‘s disease patients – a pilot study of drug immunogenicity2023 | First Faculty of Medicine
- Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's diseasePublication without faculty affiliation
- Serum infliximab trough levels and induction of antibodies to infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Excellent therapeutical effect of abatacept (Orencia) in RA patient previously unsuccessfully treated with infliximab (Remicade)2010 | Publication without faculty affiliation
- Infliximab as a treatment of inflammatory bowel disease2012 | First Faculty of Medicine
- Anorectal carcinoma after infliximab therapy in Crohn's disease : report of a case2006 | First Faculty of Medicine
- Recommendations for infliximab therapy of pediatric IBD +12008 | Faculty of Medicine in Hradec Králové
- Recommendations for infliximab therapy of pediatric IBD2008 | First Faculty of Medicine
- Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical ResponsePublication without faculty affiliation
- Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical Response.Publication without faculty affiliation
- Anti-infliximab antibodies in routine clinical practice - is it worth to assess them?Publication without faculty affiliation
- Pregnancy outcomes in women with inflammatory bowel disease treated with biosimilar infliximab2018 | First Faculty of Medicine
- Relationship Between Serum Trough Infliximab Levels and Serum Albumin in Patients With Inflammatory Bowel DiseasesPublication without faculty affiliation
- Infliximab in therapy of rheumatoid arthritis2005 | First Faculty of Medicine
- Infliximab in Treatment of Rheumatoid ArthritisPublication without faculty affiliation
- Influence of albuminemia on the pharmacokinetics of infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Biosimilar infliximab in anti-TNF-naïve IBD patients - 1-year clinical follow-up2016 | First Faculty of Medicine
- Infliximab dependency is related to decreased surgical rates in adult Crohn's disease patients2010 | First Faculty of Medicine
- Is there a real difference in the safety of infliximab treatment alone and infliximab combined with concomitant immunosuppression? Single centre experiencePublication without faculty affiliation
- Infliximab in the Treatment of Wegener ´s Granulomatosis : Case Report2006 | First Faculty of Medicine
- Long-term therapy of ankylosing spondylitis with infliximabPublication without faculty affiliation